Phase 4
Completed N=58
Comparison of Time to Extubation Using Sugammadex or Neostigmine
Neuromuscular Blockade · Chronic Obstructive Pulmonary Disease
Source: ClinicalTrials.gov NCT04606901 ↗
Enrolled (actual)
58
Serious AEs
0.0%
Results posted
Mar 2024
Primary outcomePrimary: Number of Minutes to Return of Baseline Muscle Tone — 3.9; 12.9 minutes
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
A prospective blinded randomized clinical trial to compare time to extubation using Sugammadex versus Neostigmine/glycopyrrolate as reversal agents after use of neuromuscular blockade agents in an outpatient bronchoscopy suite.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Minutes to Return of Baseline Muscle Tone |
3.9; 12.9 | — |
| SECONDARY Number of Minutes to Extubation |
11.9; 17.7 | — |
Eligibility Criteria
Inclusion Criteria
- has diagnosis of COPD or ILD
- ASA 3 or 4
- procedure requires general anesthesia in the outpatient bronchoscopy suite
- glomerular filtration rate > 30 ml/min
Exclusion Criteria
- pregnant women
- prisoners
- those unable to consent for themselves
- procedures not requiring general anesthesia
- ASA 1 or 2
Data sourced from ClinicalTrials.gov (NCT04606901). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.